For this purpose, a recently conducted experiment has shown that overexpression of ARGs such as FAM215A, MYC and FADD can provide a poor prognosis and low overall survival rate of prostate cancer patients [447]. The gene discussed is SERPINA2; the disease is prostate carcinoma.